Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.… recall — Class III (D-0321-2024) · pharmaranks
Class IIIOngoing
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35 recall
FDA recall D-0321-2024 · initiated Jan 25, 2024
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Details
Product
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.